Magnitude and Associated Factors of Diabetes Mellitus and Hypertension Among Adult HIV-positive Individuals Receiving Highly Active Antiretroviral Therapy at Jugal Hospital, Harar, Ethiopia

Overview

Journal HIV AIDS (Auckl)

Publisher Dove Medical Press

Specialty Infectious Diseases

Date 2018 Oct 24

PMID 30349400

Citations 36

Authors

Zerihun Ataro

Wondimye Ashenafi

Jiregna Fayera

Tekabe Abdosh

Affiliations

Soon will be listed here.

Abstract

Background: People with HIV infection are at increased risk of noncommunicable diseases (NCDs). Diabetes mellitus (DM) and hypertension are recognized as the major NCDs. Except few findings in general population, there is no well-documented evidence on the magnitude of NCDs and associated factors among HIV-positive patients.

Purpose: The aim of this study was to determine the magnitude and associated factors of DM and hypertension among adult HIV-positive subjects receiving highly active antiretroviral therapy (HAART).

Methods: A hospital-based cross-sectional study was conducted from February to April at Jugal Hospital, Harar, Eastern Ethiopia. Sociodemographic and anthropometric data and blood pressure (BP) were collected by senior clinical nurses. A total of 5 mL of venous blood was collected. Serum glucose and lipid profile were measured using the Autolab 18 clinical chemistry analyzer. Data were analyzed using STATA version 13.

Results: A total of 425 HIV-infected individuals taking HAART of age ranging from 18 to 68 years were included. The prevalence of DM and hypertension were 7.1% (95% CI: 4.9-9.9) and 12.7% (95% CI: 9.8-16.2), respectively. Increased blood triglyceride (adjusted odds ratio [AOR] =4.7, 95% CI: 1.7-13.1), high BP (AOR =3.3, 95% CI: 1.1-9.5), and high baseline body mass index (BMI) (AOR =8.7, 95% CI: 2.4-31.8) were significantly associated with DM. In contrast, raised waist-hip ratio (AOR =4.6, 95% CI: 1.6-13.3), raised blood glucose (AOR =3.5, 95% CI: 1.1-11.4), increased total cholesterol (AOR =3.9, 95% CI: 1.3-11.9), high current BMI (AOR =3.8, 95% CI: 1.5-9.6), drinking alcohol (AOR =3.4, 95% CI: 1.5-8.1), CD4 count <500 cell/mL (AOR =2.7, 95% CI: 1.3-5.6), and longer duration of HAART (AOR =2.3, 95% CI: 1.1-5.1) were significantly associated with hypertension.

Conclusion: DM and hypertension were frequent among HIV patients on HAART, and they were linked to the well-known risk factors. Therefore, regular screening and monitoring of DM and hypertension before and after the initiation of HAART is of paramount importance.

Citing Articles

Digital continuous glucose monitoring systems for patients with HIV-diabetes comorbidity in Ethiopia: a situational analysis.

Manyazewal T, Ali M, Kebede T, Solomon S, Hailemariam D, Patel S Sci Rep. 2024; 14(1):28862.

PMID: 39572647 PMC: 11582811. DOI: 10.1038/s41598-024-79967-y.

Prevalence and factors associated with hyperglycemia among persons living with HIV/AIDS on dolutegravir-based antiretroviral therapy in Uganda.

Byereta L, Olum R, Mutebi E, Kalyesubula R, Kagimu M, Meya D Ther Adv Infect Dis. 2024; 11:20499361241272630.

PMID: 39286262 PMC: 11403689. DOI: 10.1177/20499361241272630.

Hypertension among people living with human immunodeficiency virus in sub-Saharan Africa: a systematic review and meta-analysis.

Chen A, Chan Y, Mocumbi A, Ojji D, Waite L, Beilby J Sci Rep. 2024; 14(1):16858.

PMID: 39039244 PMC: 11263367. DOI: 10.1038/s41598-024-67703-5.

A systemic review and meta-analysis on the prevalence and associated factors of hypertension among adult clients in Ethiopia.

Ayalew T, Wale B, Zewudie B Afr Health Sci. 2024; 23(4):296-314.

PMID: 38974307 PMC: 11225477. DOI: 10.4314/ahs.v23i4.32.

The Magnitude of Hypertension and Its Contributing Factors Among Patients Receiving Antiretroviral Therapy in Public Hospitals in Harar City, Eastern Ethiopia: A Cross-Sectional Study.

Dechasa M, Nigussie S, Jambo A, Sime M, Tamire A, Kitessa M Integr Blood Press Control. 2023; 16:81-93.

PMID: 38023690 PMC: 10648178. DOI: 10.2147/IBPC.S433907.

References

Friis-Moller N, Reiss P, Sabin C, Weber R, Monforte A, El-Sadr W . Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med. 2007; 356(17):1723-35. DOI: 10.1056/NEJMoa062744. View

Saves M, Raffi F, Capeau J, Rozenbaum W, Ragnaud J, Perronne C . Factors related to lipodystrophy and metabolic alterations in patients with human immunodeficiency virus infection receiving highly active antiretroviral therapy. Clin Infect Dis. 2002; 34(10):1396-405. DOI: 10.1086/339866. View

Bergersen B, Sandvik L, Dunlop O, Birkeland K, Bruun J . Prevalence of hypertension in HIV-positive patients on highly active retroviral therapy (HAART) compared with HAART-naïve and HIV-negative controls: results from a Norwegian study of 721 patients. Eur J Clin Microbiol Infect Dis. 2003; 22(12):731-6. DOI: 10.1007/s10096-003-1034-z. View

Mary-Krause M, Cotte L, Simon A, Partisani M, Costagliola D . Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men. AIDS. 2003; 17(17):2479-86. DOI: 10.1097/00002030-200311210-00010. View

Currier J, Scherzer R, Bacchetti P, Heymsfield S, Lee D, Sidney S . Regional adipose tissue and lipid and lipoprotein levels in HIV-infected women. J Acquir Immune Defic Syndr. 2008; 48(1):35-43. PMC: 2776070. DOI: 10.1097/QAI.0b013e318164227f. View

Adewole O, Eze S, Betiku Y, Anteyi E, Wada I, Ajuwon Z . Lipid profile in HIV/AIDS patients in Nigeria. Afr Health Sci. 2011; 10(2):144-9. PMC: 2956300. View

Howard A, Floris-Moore M, Arnsten J, Santoro N, Fleischer N, Lo Y . Disorders of glucose metabolism among HIV-infected women. Clin Infect Dis. 2005; 40(10):1492-9. PMC: 2104646. DOI: 10.1086/429824. View

Nuesch R, Wang Q, Elzi L, Bernasconi E, Weber R, Cavassini M . Risk of cardiovascular events and blood pressure control in hypertensive HIV-infected patients: Swiss HIV Cohort Study (SHCS). J Acquir Immune Defic Syndr. 2013; 62(4):396-404. DOI: 10.1097/QAI.0b013e3182847cd0. View

Ahaneku G, Osuji C, Anisiuba B, Ikeh V, Oguejiofor O, Ahaneku J . Evaluation of blood pressure and indices of obesity in a typical rural community in eastern Nigeria. Ann Afr Med. 2011; 10(2):120-6. DOI: 10.4103/1596-3519.82076. View

10.

Grinspoon S . Mechanisms and strategies for insulin resistance in acquired immune deficiency syndrome. Clin Infect Dis. 2003; 37 Suppl 2:S85-90. DOI: 10.1086/375885. View

11.

Diouf A, Cournil A, Ba-Fall K, Ngom-Gueye N, Eymard-Duvernay S, Ndiaye I . Diabetes and Hypertension among Patients Receiving Antiretroviral Treatment Since 1998 in Senegal: Prevalence and Associated Factors. ISRN AIDS. 2013; 2012:621565. PMC: 3767342. DOI: 10.5402/2012/621565. View

12.

Cahn P, Leite O, Rosales A, Cabello R, Alvarez C, Seas C . Metabolic profile and cardiovascular risk factors among Latin American HIV-infected patients receiving HAART. Braz J Infect Dis. 2010; 14(2):158-66. DOI: 10.1590/s1413-86702010000200008. View

13.

Mateen F, Kanters S, Kalyesubula R, Mukasa B, Kawuma E, Kengne A . Hypertension prevalence and Framingham risk score stratification in a large HIV-positive cohort in Uganda. J Hypertens. 2013; 31(7):1372-8. DOI: 10.1097/HJH.0b013e328360de1c. View

14.

Samaras K, Wand H, Law M, Emery S, Cooper D, Carr A . Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat.... Diabetes Care. 2006; 30(1):113-9. DOI: 10.2337/dc06-1075. View

15.

Nigatu T . Integration of HIV and noncommunicable diseases in health care delivery in low- and middle-income countries. Prev Chronic Dis. 2012; 9:E93. PMC: 3431953. DOI: 10.5888/pcd9.110331. View

16.

Nsakashalo-Senkwe M, Siziya S, Goma F, Songolo P, Mukonka V, Babaniyi O . Combined prevalence of impaired glucose level or diabetes and its correlates in Lusaka urban district, Zambia: a population based survey. Int Arch Med. 2011; 4(1):2. PMC: 3035034. DOI: 10.1186/1755-7682-4-2. View

17.

Puttawong S, Prasithsirikul W, Vadcharavivad S . Prevalence of lipodystrophy in Thai-HIV infected patients. J Med Assoc Thai. 2004; 87(6):605-11. View

18.

Silva E, Bassichetto K, Lewi D . Lipid profile, cardiovascular risk factors and metabolic syndrome in a group of AIDS patients. Arq Bras Cardiol. 2009; 93(2):113-8. DOI: 10.1590/s0066-782x2009000800008. View

19.

de Arruda Junior E, Lacerda H, Moura L, de Albuquerque M, de Barros Miranda Filho D, Diniz G . Risk factors related to hypertension among patients in a cohort living with HIV/AIDS. Braz J Infect Dis. 2010; 14(3):281-7. DOI: 10.1590/s1413-86702010000300014. View

20.

Ledergerber B, Furrer H, Rickenbach M, Lehmann R, Elzi L, Hirschel B . Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study. Clin Infect Dis. 2007; 45(1):111-9. DOI: 10.1086/518619. View